| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Director | President And CEO
2 companies
Doshi Dipal is a CEO at Entrada Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $3.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | TRDA Entrada Therapeutics, Inc. | CEO | Sell | 1,900 | $17.84 | $33,897.28 | -0.3% | -0.2% | -64.3% | |
| Jun 13, 2024 | TRDA Entrada Therapeutics, Inc. | CEO | Sell | 1,000 | $16.17 | $16,173.60 | -0.3% | -9.7% | -53.9% | |
| May 17, 2024 | TRDA Entrada Therapeutics, Inc. | CEO | Sell | 3,000 | $15.04 | $45,129.12 | -0.4% | +8.5% | -46.0% | |
| Feb 15, 2024 | TRDA Entrada Therapeutics, Inc. | CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -3.5% | -10.5% | |
| Jan 16, 2024 | TRDA Entrada Therapeutics, Inc. | CEO | Sell | 1,000 | $15.99 | $15,990.00 | -0.4% | -13.7% | -18.0% | |
| Dec 20, 2023 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -15.3% | +15.3% | |
| Nov 13, 2023 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 1,000 | $16.23 | $16,230.00 | -0.4% | -7.4% | +20.7% | |
| Oct 17, 2023 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -3.8% | +13.8% | |
| Sep 13, 2023 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -8.4% | +3.4% | |
| Aug 14, 2023 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 1,000 | $15.67 | $15,671.30 | -0.5% | +6.7% | +2.9% |